|
⚲
|
| Keyboard |
| Schroeder Blake | |
|---|---|
| Firm | |
| Address | 3500 Maple Ave Suite 1600 Dallas, Texas 75219 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| LSC Naperville Holdings LLC | 021-592792 | Executive Officer | 8.5 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AXIM Biotechnologies Inc AXIM
Convertible Note · derivative
|
2024-03-15 | Grant | 35,000 | $35,000.00 | 1,225,000,000 |
|
AXIM Biotechnologies Inc AXIM
Option · derivative
|
2022-09-23 | Grant | 1,000,000 | $0.00 | |
|
AXIM Biotechnologies Inc AXIM
Common Stock
|
2022-08-22 | Conversion | 854,012 | $0.03 | 25,620 |
|
AXIM Biotechnologies Inc AXIM
Convertible Note (Convertible into Common Stock) · derivative
|
2022-02-10 | Other | 25,000 | $25,000.00 | 625,000,000 |
|
Neuropathix Inc NPTX
Employee Stock Option (Right to Buy) · derivative
|
2021-03-12 | Grant | 600,000 | $0.00 | |
|
Neuropathix Inc KLFE
Stock Option (Right to Buy) · derivative
|
2020-05-04 | Grant | 300,000 | $0.00 | |
|
Neuropathix Inc KLFE
Common Stock
|
2019-08-14 | Grant | 250,000 | $0.10 | 25,000 |